EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing VirScan serosurvey epitope profiling variability between in-clinic venous blood draw and capillary blood self-sampling device

Linda M Sircy iD, Terry L Stevens-Ayers iD, Elizabeth M Krantz, Laurel Joncas-Schronce, Nina S O Ozbek, Rachel L Blazevic, Larry Mose, Louise E Kimball, Ryan Basom, Sayan Dasgupta, Antje Heit, Frank Schmitz und 6 weitere

Microbiology Spectrum · 02.06.2026 · 14 (6)

DOI: 10.1128/spectrum.02454-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 02.06.2026. Verfasst von Linda M Sircy und 17 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Blood Specimen Collection, Epitopes. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amazon, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Timely and ongoing in-clinic sample collections are a common logistical barrier to volunteer participation and retention in longitudinal clinical studies. To remove this barrier, clinical studies have recently begun to implement the use of at-home capillary blood self-sampling devices in place of in-clinic venous blood draws for participant blood sample collection. Thus, we assessed antibody responses to a broad library of over 300 viral, bacterial, and fungal pathogens using VirScan immunoassay testing on adult volunteer capillary (serum) and venous (plasma) blood samples collected by Tasso devices and in-clinic venipunctures on the same day to determine whether self-sampling devices are a more practical and convenient alternative for future clinical studies. Most VirScan measurements of antibodies specific for clinically relevant respiratory viruses and herpesviruses had strong concordance between participant-matched Tasso and venipuncture blood samples. While we did not identify a systematic bias in most pathogen-specific antibody measurements associated with blood collection method, we did observe intrinsic VirScan inter-assay variability across some clinically relevant viruses. Together, our data demonstrate that capillary blood self-sampling devices are a practical alternative to in-clinic venipunctures for VirScan clinical research studies. However, these blood collection methods should not be used interchangeably within longitudinal studies to minimize the introduction of technical variables. IMPORTANCE Our study assessed whether capillary blood self-sampling devices could reliably replace in-clinic venous blood collection methods for the VirScan immunoassay, which can detect antibodies specific to hundreds of pathogens. Longitudinal studies requiring multiple in-clinic visits for sample collection often experience low volunteer retention because of the inconvenience of traveling to research sites. Allowing volunteers to use at-home self-sampling devices reduces the burden of travel for participants and increases access to outreach for volunteers who would otherwise not participate in research. Importantly, VirScan only requires a small sample volume, so blood self-sampling devices would be appropriate to use despite their volume collection limitations. Overall, capillary blood self-sampling devices can be a reliable and efficient method for research studies to investigate antibody responses longitudinally using VirScan. However, to limit the introduction of technical variables, collection methods should not be used interchangeably within a longitudinal study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Specimen CollectionEpitopesHumansAntibodies, ViralAdultImmunoassayPhlebotomyFemaleSpecimen HandlingMaleViruses

Stichwörter der Autor:innen

VirScanantibody profilingblood self-samplingepitope profiling

Substanzen

Antibodies, ViralEpitopes

Autor:innen und Institutionen

  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Amazon, Seattle, Washington, USA.
  • Department of Pediatrics, University of Washington, Seattle, Washington, USA.
  • Seattle Children's Research Institute, Seattle, Washington, USA.

ORCID-Profile: Linda M Sircy, Terry L Stevens-Ayers, Joshua A Hill, Michael Boeckh, Alpana Waghmare

Förderung

  • Amazon
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Sircy, L. M., Stevens-Ayers, T. L., Krantz, E. M., Joncas-Schronce, L., Ozbek, N. S. O., Blazevic, R. L., Mose, L., Kimball, L. E., Basom, R., Dasgupta, S., Heit, A., Schmitz, F., Heckerman, D., Bender Ignacio, R. A., Hill, J. A., Boonyaratanakornkit, J., Boeckh, M., & Waghmare, A. (2026). Assessing VirScan serosurvey epitope profiling variability between in-clinic venous blood draw and capillary blood self-sampling device. Microbiology Spectrum, 14(6). https://doi.org/10.1128/spectrum.02454-25

Vancouver

Sircy LM, Stevens-Ayers TL, Krantz EM, Joncas-Schronce L, Ozbek NSO, Blazevic RL, et al. Assessing VirScan serosurvey epitope profiling variability between in-clinic venous blood draw and capillary blood self-sampling device. Microbiology Spectrum. 2026;14(6). doi:10.1128/spectrum.02454-25

BibTeX
@article{Sircy2026,
  author = {Sircy, Linda M and Stevens-Ayers, Terry L and Krantz, Elizabeth M and Joncas-Schronce, Laurel and Ozbek, Nina S O and Blazevic, Rachel L and Mose, Larry and Kimball, Louise E and Basom, Ryan and Dasgupta, Sayan and Heit, Antje and Schmitz, Frank and Heckerman, David and Bender Ignacio, Rachel A and Hill, Joshua A and Boonyaratanakornkit, Jim and Boeckh, Michael and Waghmare, Alpana},
  title = {Assessing VirScan serosurvey epitope profiling variability between in-clinic venous blood draw and capillary blood self-sampling device},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.1128/spectrum.02454-25}
}
Kostenlos starten →